The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

SGEN 15.43%
SGEN $100.89 13.49 (15.43%)
Seattle Genetics
NASDAQ: SGEN $11 Billion Large-Cap. Show More

SGEN Profile

Market Cap 11 Billion
SGEN Description

Seattle Genetics is a biotech firm focused on the development of monoclonal antibody-based therapies. The company's lead product, Adcetris, has received approval for advanced frontline, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. The company has several other early-stage programs in trials. Seattle Genetics also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies.

Visit Website

SGEN Earnings

EPS -0.49 P/E Ratio 0.00
Previous Tue, Jul 16, 2019
Latest Tue, Oct 29, 2019 (In 7 days)

SGEN Dividend

Yield --
Ex-Date --
Pay Date --
History --

SGEN Charts

All Time High $102.84 on Mon, Oct 21, 2019.
1 Year
Oct 30, 2018

Symbol Price Day Ξ” YTD Ξ”
SGEN $100.89 15.43% 75.49%


Symbol Surfing

How can we make Symbol Surfing better?


©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy